Michael F. Parker

Person

Higganum, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
3-substituted propionic acids as αV integrin inhibitors
- Patent number 11,884,661
- Issue date Jan 30, 2024
- Bristol-Myers Squibb Company
- Guohua Zhao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxazolidinones as modulators of MGLUR5
- Patent number RE49735
- Issue date Nov 28, 2023
- Bristol-Myers Squibb Company
- Andrew P. Degnan
Information Patent Grant
3-substituted propionic acids as αV integrin inhibitors
- Patent number 10,968,219
- Issue date Apr 6, 2021
- Bristol-Myers Squibb Company
- Guohua Zhao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic inhibitors of PAD4
- Patent number 9,963,448
- Issue date May 8, 2018
- Padlock Therapeutics, Inc.
- Rajesh Devraj
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxazolidinones as modulators of mGluR5
- Patent number 9,688,669
- Issue date Jun 27, 2017
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxazolidinones as modulators of mGluR5
- Patent number 8,691,821
- Issue date Apr 8, 2014
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
- Patent number 8,513,253
- Issue date Aug 20, 2013
- Bristol-Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic ethers and their use in CNS disorders
- Patent number 8,071,778
- Issue date Dec 6, 2011
- Bristol-Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
- Patent number 7,786,122
- Issue date Aug 31, 2010
- Bristol-Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
- Patent number 7,300,936
- Issue date Nov 27, 2007
- Bristol-Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiamyloid phenylsulfonamides: N-alkanol derivatives
- Patent number 6,989,399
- Issue date Jan 24, 2006
- Bristol-Myers Squibb Company
- David W. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide compounds and uses thereof
- Patent number 6,967,196
- Issue date Nov 22, 2005
- Bristol-Myers Squibb Company
- David W. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzopyran derivatives as melatonergic agents
- Patent number 6,060,506
- Issue date May 9, 2000
- Bristol-Myers Squibb Company
- John D. Catt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzodioxa alkylene ethers as melatonergic agents
- Patent number 5,981,571
- Issue date Nov 9, 1999
- Bristol-Myers Squibb Company
- John D. Catt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-acyl-2-aryl cyclopropylmethylamine derivatives as melatonergics
- Patent number 5,889,031
- Issue date Mar 30, 1999
- Bristol-Myers Squibb Compnay
- Daniel J. Keavy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzofuran and dihydrobenzofuran melatonergic agents
- Patent number 5,856,529
- Issue date Jan 5, 1999
- Bristol-Myers Squibb Company
- John D. Catt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
- Patent number 5,753,709
- Issue date May 19, 1998
- Bristol-Myers Squibb Company
- Daniel J. Keavy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Melatonergic agents
- Patent number 5,661,185
- Issue date Aug 26, 1997
- Bristol-Myers Squibb Co.
- Katherine S Takaki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-acyl-cycloalkylamine derivatives as melatonergics
- Patent number 5,596,019
- Issue date Jan 21, 1997
- Bristol-Myers Squibb Company
- Ronald J. Mattson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Melatonergic agents
- Patent number 5,541,228
- Issue date Jul 30, 1996
- Bristol-Myers Squibb Co.
- Katherine S Takaki
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS
- Publication number 20210188847
- Publication date Jun 24, 2021
- Bristol-Myers Squibb Company
- Guohua ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS
- Publication number 20190263808
- Publication date Aug 29, 2019
- Bristol-Myers Squibb Company
- Guohua ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC INHIBITORS OF PAD4
- Publication number 20170166565
- Publication date Jun 15, 2017
- Padlock Therapeutics, Inc.
- Rajesh Devraj
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OXAZOLIDINONES AS MODULATORS OF MGLUR5
- Publication number 20160237072
- Publication date Aug 18, 2016
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxazolidinones as Modulators of MGLUR5
- Publication number 20120283264
- Publication date Nov 8, 2012
- Bristol -Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors
- Publication number 20110105485
- Publication date May 5, 2011
- Bristol -Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Heterocyclic Ethers and Their Use in CNS Disorders
- Publication number 20090030040
- Publication date Jan 29, 2009
- Bristol -Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS
- Publication number 20080085894
- Publication date Apr 10, 2008
- Bristol -Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS
- Publication number 20080027056
- Publication date Jan 31, 2008
- Bristol -Myers Squibb Company
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Alpha-(N-sulfonamido)acetamide derivatives as beta-amyloid inhibitors
- Publication number 20040127494
- Publication date Jul 1, 2004
- Michael F. Parker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antiamyloid phenylsulfonamides: N-alkanol derivatives
- Publication number 20040097572
- Publication date May 20, 2004
- David W. Smith
- C07 - ORGANIC CHEMISTRY

Michael F. Parker

Person

Patents Grantslast 30 patents

3-substituted propionic acids as αV integrin inhibitors

Oxazolidinones as modulators of MGLUR5

3-substituted propionic acids as αV integrin inhibitors

Bicyclic inhibitors of PAD4

Oxazolidinones as modulators of mGluR5

Oxazolidinones as modulators of mGluR5

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

Substituted heterocyclic ethers and their use in CNS disorders

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

Antiamyloid phenylsulfonamides: N-alkanol derivatives

Sulfonamide compounds and uses thereof

Benzopyran derivatives as melatonergic agents

Benzodioxa alkylene ethers as melatonergic agents

N-acyl-2-aryl cyclopropylmethylamine derivatives as melatonergics

Benzofuran and dihydrobenzofuran melatonergic agents

N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics

Melatonergic agents

N-acyl-cycloalkylamine derivatives as melatonergics

Melatonergic agents

Patents Applicationslast 30 patents

3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS

3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS

BICYCLIC INHIBITORS OF PAD4

OXAZOLIDINONES AS MODULATORS OF MGLUR5

Oxazolidinones as Modulators of MGLUR5

Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors

Substituted Heterocyclic Ethers and Their Use in CNS Disorders

ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS

SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS

Alpha-(N-sulfonamido)acetamide derivatives as beta-amyloid inhibitors

Antiamyloid phenylsulfonamides: N-alkanol derivatives